001     143209
005     20240229112544.0
024 7 _ |a 10.1016/j.jaad.2018.09.018
|2 doi
024 7 _ |a pmid:30244061
|2 pmid
024 7 _ |a 0190-9622
|2 ISSN
024 7 _ |a 1097-6787
|2 ISSN
024 7 _ |a altmetric:48829801
|2 altmetric
037 _ _ |a DKFZ-2019-00808
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Brunssen, Alicia
|b 0
245 _ _ |a A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype.
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1555072653_31258
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Differences in relative survival (RS) of melanoma between histologic subtypes were discussed to be mainly caused by tumor thickness.To investigate RS of melanoma, stratified by tumor thickness for each histologic subtype, and identify survival trends.With use of cancer registry data on melanoma cases (International Classification of Diseases, 10th Revision, codes C43.0-C43.9) diagnosed in Germany in 1997-2013, 5- and 10-year age-standardized RS stratified by histologic subtype and stratified or standardized by T stage was estimated by standard and modeled period analyses. We restricted 10-year RS analyses to patients younger than 75 years.We analyzed 82,901 cases. Overall, the 5- and 10-year RS rates were 91.7% and 90.8%, respectively. Prognosis worsened with increasing T stage for all histologic subtypes, but T-stage distribution varied substantially. Survival differences by histologic subtype were strongly alleviated after adjustment for T stage but remained significant. Overall, 5-year RS increased significantly (by 3.8 percentage points) between the periods 2002-2005 and 2010-2013. This increase was no longer seen after adjustment for T stage.Exclusion of cases on account of missing information on T stages, changes in the definition of T stages, and lack of information on screening and treatment limit our analyses.Differences in RS between histologic subtypes were strongly mediated by tumor thickness. Over time, RS of melanoma increased as a result of changes in T-stage distribution.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Jansen, Lina
|0 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09
|b 1
|u dkfz
700 1 _ |a Eisemann, Nora
|b 2
700 1 _ |a Waldmann, Annika
|b 3
700 1 _ |a Weberpals, Janick
|0 P:(DE-He78)bf5409aed74a0923d9402c2c7ad620aa
|b 4
|u dkfz
700 1 _ |a Kraywinkel, Klaus
|b 5
700 1 _ |a Eberle, Andrea
|b 6
700 1 _ |a Holleczek, Bernd
|b 7
700 1 _ |a Zeissig, Sylke Ruth
|b 8
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 9
|u dkfz
700 1 _ |a Katalinic, Alexander
|b 10
700 1 _ |a Group, GEKID Cancer Survival Working
|b 11
|e Collaboration Author
700 1 _ |a Geiss, Karla
|b 12
700 1 _ |a Meyer, Martin
|b 13
700 1 _ |a Luttmann, Sabine
|b 14
700 1 _ |a Stabenow, Roland
|b 15
700 1 _ |a Hentschel, Stefan
|b 16
700 1 _ |a Nennecke, Alice
|b 17
700 1 _ |a Kieschke, Joachim
|b 18
700 1 _ |a Sirri, Eunice
|b 19
700 1 _ |a Emrich, Katharina
|b 20
700 1 _ |a Kajüter, Hiltraud
|b 21
700 1 _ |a Mattauch, Volkmar
|b 22
773 _ _ |a 10.1016/j.jaad.2018.09.018
|g Vol. 80, no. 4, p. 938 - 946
|0 PERI:(DE-600)2001404-1
|n 4
|p 938 - 946
|t Journal of the American Academy of Dermatology
|v 80
|y 2019
|x 0190-9622
909 C O |p VDB
|o oai:inrepo02.dkfz.de:143209
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)bbfe0ebad1e3b608bca2b49d4f86bd09
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)bf5409aed74a0923d9402c2c7ad620aa
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J AM ACAD DERMATOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J AM ACAD DERMATOL : 2017
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l Klinische Epidemiologie und Alternsforschung
|x 0
920 1 _ |0 I:(DE-He78)L101-20160331
|k L101
|l DKTK Heidelberg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)L101-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21